![N-(2-hydroxy-2-phenylethyl)-2-(2,3,4,9-tetramethyl-7-oxo-7H-furo[2,3-f]chromen-8-yl)acetamide structure](/static/products/896/896063-65-3.png)
N-(2-hydroxy-2-phenylethyl)-2-(2,3,4,9-tetramethyl-7-oxo-7H-furo[2,3-f]chromen-8-yl)acetamide
TL;DR: N-(2-hydroxy-2-phenylethyl)-2-(2,3,4,9-tetramethyl-7-oxo-7H-furo[2,3-f]chromen-8-yl)acetamide (CAS 896063-65-3) is a chemical compound with molecular formula C25H25NO5 and molecular weight 419.17 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
N-(2-hydroxy-2-phenylethyl)-2-(2,3,4,9-tetramethyl-7-oxofuro[2,3-f]chromen-8-yl)acetamide
Also Known As: N-(2-hydroxy-2-phenylethyl)-2-(2,3,4,9-tetramethyl-7-oxo-7H-furo[2,3-f]chromen-8-yl)acetamide, N-(2-hydroxy-2-phenylethyl)-2-(2,3,4,9-tetramethyl-7-oxofuro[2,3-f]chromen-8-yl)acetamide
| Molecular Formula | C25H25NO5 |
|---|---|
| Molecular Weight | 419.17 g/mol |
| LogP | 4.16518 |
| Topological Polar Surface Area | 92.68 Ų |
| Hydrogen Bond Donors | 2 |
| Hydrogen Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Exact Mass | 419.17328 |
| Heavy Atoms | 31 |
| Complexity | 1347.8485 |
Chemical Identifiers
| CAS Number | 896063-65-3 |
|---|---|
| SMILES | CC1=CC2=C(C(=C(C(=O)O2)CC(=O)NCC(C3=CC=CC=C3)O)C)C4=C1C(=C(O4)C)C |
Product Overview
N-(2-hydroxy-2-phenylethyl)-2-(2,3,4,9-tetramethyl-7-oxo-7H-furo[2,3-f]chromen-8-yl)acetamide (CAS 896063-65-3), with molecular formula C25H25NO5 and molecular weight 419.17 g/mol. IUPAC: N-(2-hydroxy-2-phenylethyl)-2-(2,3,4,9-tetramethyl-7-oxofuro[2,3-f]chromen-8-yl)acetamide.
Chemical Property Profile of N-(2-hydroxy-2-phenylethyl)-2-(2,3,4,9-tetramethyl-7-oxo-7H-furo[2,3-f]chromen-8-yl)acetamide
Property Insights of N-(2-hydroxy-2-phenylethyl)-2-(2,3,4,9-tetramethyl-7-oxo-7H-furo[2,3-f]chromen-8-yl)acetamide
The XLogP value of 4.16518 indicates that N-(2-hydroxy-2-phenylethyl)-2-(2,3,4,9-tetramethyl-7-oxo-7H-furo[2,3-f]chromen-8-yl)acetamide is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. The TPSA of 92.68 Ų falls within the moderate polarity range, balancing permeability and solubility for N-(2-hydroxy-2-phenylethyl)-2-(2,3,4,9-tetramethyl-7-oxo-7H-furo[2,3-f]chromen-8-yl)acetamide. Following Lipinski's Rule of Five, N-(2-hydroxy-2-phenylethyl)-2-(2,3,4,9-tetramethyl-7-oxo-7H-furo[2,3-f]chromen-8-yl)acetamide has 2 hydrogen bond donor(s) and 5 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of N-(2-hydroxy-2-phenylethyl)-2-(2,3,4,9-tetramethyl-7-oxo-7H-furo[2,3-f]chromen-8-yl)acetamide?
The CAS number of N-(2-hydroxy-2-phenylethyl)-2-(2,3,4,9-tetramethyl-7-oxo-7H-furo[2,3-f]chromen-8-yl)acetamide is 896063-65-3.
What is the molecular formula of N-(2-hydroxy-2-phenylethyl)-2-(2,3,4,9-tetramethyl-7-oxo-7H-furo[2,3-f]chromen-8-yl)acetamide?
The molecular formula of N-(2-hydroxy-2-phenylethyl)-2-(2,3,4,9-tetramethyl-7-oxo-7H-furo[2,3-f]chromen-8-yl)acetamide is C25H25NO5.
What is the molecular weight of N-(2-hydroxy-2-phenylethyl)-2-(2,3,4,9-tetramethyl-7-oxo-7H-furo[2,3-f]chromen-8-yl)acetamide?
The molecular weight of N-(2-hydroxy-2-phenylethyl)-2-(2,3,4,9-tetramethyl-7-oxo-7H-furo[2,3-f]chromen-8-yl)acetamide is 419.17 g/mol.
Where can I buy N-(2-hydroxy-2-phenylethyl)-2-(2,3,4,9-tetramethyl-7-oxo-7H-furo[2,3-f]chromen-8-yl)acetamide?
You can request a quote for N-(2-hydroxy-2-phenylethyl)-2-(2,3,4,9-tetramethyl-7-oxo-7H-furo[2,3-f]chromen-8-yl)acetamide directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for N-(2-hydroxy-2-phenylethyl)-2-(2,3,4,9-tetramethyl-7-oxo-7H-furo[2,3-f]chromen-8-yl)acetamide?
Yes, KEHONG BIO provides custom synthesis services for N-(2-hydroxy-2-phenylethyl)-2-(2,3,4,9-tetramethyl-7-oxo-7H-furo[2,3-f]chromen-8-yl)acetamide and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.